semaglutide microdosing schedule GLP-1s Is Gaining Popularity—But Does It Work? Microdosing GLP-1's for Weight Loss

Br J Pharmacol 179(4):659676 Hernandez AF, Green JB, Janmohamed S, DAgostino Sr RB, Granger CB, Jones NP, et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Methods A national two-round Delphi study was conducted to reach a consensus on the barriers and strategies to prescribing GLP-1 RAs in patients with CV risk or established CVD [28,29,30]

GLP-1 receptor agonists, SGLT2 inhibitors and DPP-4 inhibitors GLP-1 receptor agonists, sodium glucose co-transporter-2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors reduce the risk of MACE compared to placebo

The minimum dose is two or three sessions a week of basic compound lifts